Cargando…
Release of ranibizumab using a porous poly(dimethylsiloxane) capsule suppressed laser-induced choroidal neovascularization via the transscleral route
The administration of anti-vascular endothelial growth factor drugs in the posterior eye segment with sustained release through less invasive methods is a challenge in the treatment of age-related macular disease. We developed a flexible capsule device using porous poly(dimethylsiloxane) (PDMS) that...
Autores principales: | Nagai, Nobuhiro, Daigaku, Reiko, Motoyama, Remi, Kaji, Hirokazu, Abe, Toshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805412/ https://www.ncbi.nlm.nih.gov/pubmed/36586040 http://dx.doi.org/10.1007/s10856-022-06705-z |
Ejemplares similares
-
Application of clotrimazole via a novel controlled release device provides potent retinal protection
por: Nezhad, Zhaleh Kashkouli, et al.
Publicado: (2015) -
Transscleral Sustained Vasohibin-1 Delivery by a Novel Device Suppressed Experimentally-Induced Choroidal Neovascularization
por: Onami, Hideyuki, et al.
Publicado: (2013) -
A comparative study between a transscleral sustained-release device and eyedrops on intraocular distribution of carteolol hydrochloride
por: Hashikawa, Yoshiko, et al.
Publicado: (2023) -
Choroidal Osteoma and Secondary Choroidal Neovascularization Treated with Ranibizumab
por: Sarıgül Sezenöz, Almila, et al.
Publicado: (2017) -
Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
por: Ellabban, Abdallah A, et al.
Publicado: (2012)